# CLINICAL PRODUCTS CENTER (CPC) for IMMUNE-MEDIATED DISEASES

> **NIH NIH N01** · — · 2022 · $1,045,000

## Abstract

The Clinical Product Center under contract, provides Investigational Product Services for all DAIT-funded and/or sponsored clinical research programs and other NIAID-funded clinical trials as needed.  Studies to be supported encompass a broad range of immune-mediated & rare diseases, including: (i) asthma and allergic diseases; (ii) autoimmune disorders; (iii) immune-mediated rejection in solid organ, tissue and cell transplantation; and (iv)  (v) Basic Science studies (Opioid Vaccine studies).  Additionally, and on an as-needed basis, clinical trials of infectious disease treatment, prevention and other vaccine studies.  Investigational Products to be studied include schedule I through VI pharmaceutical agents, biologics, foods as study interventions, and other agents.

## Key facts

- **NIH application ID:** 10551069
- **Project number:** 75N93019C00003-P00008-9999-1
- **Recipient organization:** —
- **Principal Investigator:** RAGHUVEERA YARAMOLU
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,045,000
- **Award type:** —
- **Project period:** 2019-04-01 → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10551069

## Citation

> US National Institutes of Health, RePORTER application 10551069, CLINICAL PRODUCTS CENTER (CPC) for IMMUNE-MEDIATED DISEASES (75N93019C00003-P00008-9999-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10551069. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*